Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Shapiro

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
Journal of Surgical Oncology|February 1, 1982
Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breastC M Shapiro, D Schifeling, J D Bitran, et al.
Medical Care|September 22, 2001
Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings ScaleG M Devins, R Dion, L G Pelletier, et al.
Chronobiology International|October 25, 2019
Psoriatic and psoriatic arthritis patients with and without jet-lag: does it matter for disease severity scores? Insights and implications from a pilot, prospective studyG Damiani, N L Bragazzi, S Garbarino, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
Journal of Surgical Oncology|February 1, 1982
Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breastC M Shapiro, D Schifeling, J D Bitran, et al.
Medical Care|September 22, 2001
Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings ScaleG M Devins, R Dion, L G Pelletier, et al.
Chronobiology International|October 25, 2019
Psoriatic and psoriatic arthritis patients with and without jet-lag: does it matter for disease severity scores? Insights and implications from a pilot, prospective studyG Damiani, N L Bragazzi, S Garbarino, et al.
Pageof 15